HYDROS TRUS Probe

by PROCEPT BioRobotics  · Based in United States → — Robotic Treatments for Men's Health
Radiology Urology

Regulatory Status Disclosed

Overview

The HYDROS Robotic System, which includes the HYDROS TRUS Probe, is an advanced, AI-powered platform designed for Aquablation therapy. This system provides a minimally invasive, robotic-assisted waterjet treatment for benign prostatic hyperplasia (BPH). It integrates AI-powered treatment planning with FirstAssist AI™, advanced image guidance through next-generation ultrasound imaging, digital cystoscopy, and dual high-definition touchscreens, and precise robotic resection using a heat-free waterjet. The HYDROS TRUS Probe itself is a reusable biplane transrectal ultrasound probe that works in conjunction with the HYDROS Robotic System and HYDROS Handpiece to provide essential ultrasound imaging during the Aquablation procedure. The system is engineered to enhance efficiency, improve surgeon and staff experience, and deliver accurate and consistent treatment plans for patients suffering from lower urinary tract symptoms (LUTS) due to BPH, while aiming to preserve sexual function and continence.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered treatment planning (FirstAssist AIu2122)
  • Advanced image guidance (next-generation ultrasound, digital cystoscopy, dual HD touchscreens)
  • Robotic-assisted heat-free waterjet resection
  • Streamlined workflow
  • Real-time ultrasound imaging
  • Personalized and anatomy-specific therapy
  • Robotic precision and reproducibility
  • Treatment for benign prostatic hyperplasia (BPH)

Use Cases

  • Treatment of benign prostatic hyperplasia (BPH)
  • Resection and removal of prostate tissue in males with LUTS due to BPH
  • Minimally invasive urologic surgery

What Physicians Need to Know

DICOM Support & Standards
The HYDROS Robotic System integrates next-generation ultrasound imaging and digital cystoscopy, providing surgeons with a multi-dimensional, detailed view of the entire prostate. The system also uses AI-interpreted, real-time ultrasound imaging and advanced image-guided treatment planning.
Reading Room Workflow Impact
The HYDROS Robotic System, including the HYDROS TRUS Probe, is designed to improve efficiency and streamline workflow during Aquablation therapy for BPH. It aims to enhance surgeon and staff experience and deliver more accurate and consistent treatment plans. The system integrates real-time ultrasound imaging and digital cystoscopy, allowing surgeons to see both ultrasonic and cystoscopic images on the same screen, which can save time.
AI Model Architecture (deep learning approach)
The HYDROS Robotic System features FirstAssist AI™ treatment planning, which is built on data from over 50,000 real-world Aquablation procedures. This AI uses image recognition software to provide an optimal treatment plan for each patient, identifying critical anatomy on ultrasound to aid the surgeon. The system leverages AI-interpreted, real-time ultrasound imaging and advanced image-guided treatment planning.
Processing Speed (per study)
Most prostate procedures under 100g take approximately 30 minutes, while larger glands greater than 100g are typically completed in 45–50 minutes (from TRUS probe insertion to Foley placement). The Aquablation part of the procedure can take 10 to 15 minutes. The Aquablation procedure typically takes an hour and may involve an overnight stay.
FDA Clearance Pathway (510k/De Novo)
The HYDROS Robotic System, which includes the HYDROS TRUS Probe, received FDA 510(k) clearance on August 21, 2024. A subsequent 510(k) for the HYDROS Robotic System, HYDROS TRUS Probe, and HYDROS Handpiece was cleared on October 10, 2025.
Supported Modalities (CT/MRI/X-ray/US)
The HYDROS TRUS Probe is a biplane transrectal ultrasound probe used in conjunction with the HYDROS Robotic System to provide ultrasound imaging. The system integrates next-generation ultrasound imaging and digital cystoscopy.
Sensitivity & Specificity Data
Clinical studies have shown that Aquablation therapy provides significant, durable BPH symptom relief while preserving sexual function and continence. Specifically, 100% of patients were free from erectile dysfunction, 89% preserved ejaculatory function, and over 99% did not have incontinence after Aquablation therapy. The procedure has shown a lower complication rate and fewer retreatments compared to transurethral resection of the prostate (TURP).
Physician Tip

The HYDROS TRUS Probe is a reusable component of the HYDROS Robotic System, which utilizes AI-powered treatment planning (FirstAssist AI™) and real-time ultrasound guidance for Aquablation therapy in BPH. This system aims to provide precise, anatomy-specific treatment while preserving sexual function and continence. Be aware of the importance of proper reprocessing of the probe after each use. The system is designed to streamline workflow and enhance efficiency in the operating room. The HYDROS Robotic System is indicated for the resection and removal of prostate tissue in males suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The intended user should be a urologist trained and familiar with endoscopic surgical procedures for BPH and TRUS imaging. It is crucial to avoid excessive force when manipulating the TRUS probe to prevent rectal injury.

The HYDROS TRUS Probe is an integral part of the HYDROS Robotic System, working in conjunction with the HYDROS Handpiece to provide ultrasound imaging during Aquablation procedures. The system integrates next-generation ultrasound imaging and digital cystoscopy, offering a multi-dimensional view of the prostate. The AI-powered treatment planning software, FirstAssist AI™, is a core component of this integrated system.

Details

Category Radiology & Imaging AI, Surgical AI
Pricing Unknown
Free Trial No
DeploymentOn-premise
Mobile AppNo
API Available No
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Radiology, Urology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-10-10K251082 510(k)HYDROS TRUS Probe

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate HYDROS TRUS Probe

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for HYDROS TRUS Probe.

View all on YouTube

Frequently Asked Questions

The HYDROS TRUS Probe is a biplane transrectal ultrasound probe that works in conjunction with the HYDROS Robotic System and HYDROS Handpiece to provide ultrasound imaging for Aquablation procedures. The HYDROS Robotic System features FirstAssist AI™ treatment planning, which leverages insights from over 50,000 procedures to assist the surgeon in interpreting ultrasound images for key anatomical landmarks and suggesting an optimal, patient-specific treatment plan. This AI-powered approach helps to improve the accuracy of landmark identification and standardize the procedure.
The HYDROS TRUS Probe is a reusable, non-sterile device that requires reprocessing prior to each use according to the instructions for use. The HYDROS Robotic System, which includes the TRUS Probe, received FDA 510(k) clearance on August 21, 2024, and is indicated for the resection and removal of prostate tissue in males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. The intended user is a urologist, supported by OR staff, who is trained and familiar with endoscopic surgical procedures for BPH, managing complications, and TRUS imaging.
While the HYDROS TRUS Probe is part of a system that uniquely combines real-time, ultrasound-guided, robotic-assisted, heat-free waterjet technology for BPH treatment, other robotic systems exist for various interventional radiology procedures. Some robotic systems use wired joystick controls for needle placement with greater accuracy than manual techniques, and AI is also being used in radiomics to improve prognostic assessment. However, the HYDROS system's specific combination of advanced ultrasound imaging, digital cystoscopy, AI-powered treatment planning, and robotic waterjet resection for BPH appears to be a distinct offering.
PROCEPT BioRobotics reported an average selling price of approximately $495,000 for new HYDROS systems in Q2 2026. Additionally, there is a cost of roughly $3,550 per single-use handpiece per procedure. While this information pertains to the entire HYDROS Robotic System, the TRUS Probe is an integral component of that system.
One potential challenge identified in a reported event was fluid ingress within two HYDROS TRUS probes, which caused imaging to appear "glitchy" and led to the abortion of a procedure. The root cause was determined to be user reprocessing of the probes. This highlights the importance of strict adherence to reprocessing instructions. Additionally, while AI can accurately identify many radiographic abnormalities, accurate diagnosis ultimately depends on integrating AI-generated findings with procedural details, bedside clinical assessment, and confirmatory imaging when clinically indicated, as AI systems may not inherently incorporate procedural or clinical information into diagnostic interpretation.

Related Tools

RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364)
Spectrum Dynamics Medical
Radiology & Imaging AI
The VERITON-CT 300 Series Digital SPECT/CT System is a new-generation SPECT/CT system that wraps 360° around the patient's body contour for a personalized exam, utilizing 12 digital CZT detectors for accurate and confident diagnoses.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
MAGNETOM Vida, MAGNETOM Sola, MAGNETOM Lumina, MAGNETOM Altea
Siemens Medical Solutions USA
Radiology & Imaging AI
Siemens Medical Solutions USA, Inc. provides innovative medical technologies and services that enhance healthcare delivery, specializing in advanced medical imaging systems like the MAGNETOM MRI series.

See all Radiology & Imaging AI tools →

More from Procept Biorobotics

HYDROS Handpiece
PROCEPT BioRobotics
Surgical AI
The HYDROS Handpiece is a single-use component of Procept Biorobotics' HYDROS Robotic System, an AI-powered surgical platform for Aquablation therapy, treating benign prostatic hyperplasia (BPH) with precision and heat-free waterjet resection.
HYDROS Robotic System
PROCEPT BioRobotics
Surgical AI
The HYDROS Robotic System by Procept Biorobotics is an AI-powered surgical robot for Aquablation therapy, treating benign prostatic hyperplasia (BPH) with advanced image guidance and robotic precision to preserve sexual function and continence.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-12 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.